EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey
Launched by EUROPEAN ALLIANCE OF ASSOCIATIONS IN RHEUMATOLOGY · Jun 10, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey is a study designed to understand how rheumatic and musculoskeletal diseases (like arthritis and other joint or muscle disorders) affect the lives of patients. By completing regular questionnaires, participants will share important information about their health care experiences and how their conditions impact their daily activities, work, and social lives. This information will be valuable for researchers and healthcare providers, helping to improve treatment and support for individuals living with these diseases.
To take part in this survey, you need to be at least 18 years old, live in a European country that is part of EULAR, and have been diagnosed with one of these diseases. You’ll also need a valid email address and the ability to use an internet website to complete the questionnaires. There are no specific exclusions, so most people meeting these criteria are welcome to join. Your contributions will help shed light on the challenges faced by many, ultimately aiming to enhance care for everyone affected by rheumatic and musculoskeletal diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-year-old at time of baseline survey
- • Living in a EULAR country at time of baseline survey
- • Diagnosed with at least one RMD
- • Valid personal e-mail address
- • Being able to use an internet website
- Exclusion Criteria:
- • none
About European Alliance Of Associations In Rheumatology
The European Alliance of Associations in Rheumatology (EULAR) is a leading organization dedicated to advancing the understanding and treatment of rheumatic and musculoskeletal diseases through collaborative research, education, and advocacy. As a clinical trial sponsor, EULAR fosters innovative studies that aim to improve patient outcomes and promote best practices in rheumatology. By uniting healthcare professionals, researchers, and patient organizations, EULAR seeks to enhance the quality of care and drive progress in the field, ensuring that scientific discoveries translate effectively into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kilchberg, Zurich, Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported